Kynurenine structure
|
Common Name | Kynurenine | ||
|---|---|---|---|---|
| CAS Number | 343-65-7 | Molecular Weight | 208.214 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 466.6±45.0 °C at 760 mmHg | |
| Molecular Formula | C10H12N2O3 | Melting Point | ~235 °C (dec.) | |
| MSDS | USA | Flash Point | 236.0±28.7 °C | |
Use of KynurenineKynurenine is a metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway. It causes vasodilation and hypotension induced by activation of KCNQ-encoded voltage-dependent K(+) channels.. |
| Name | kynurenine |
|---|---|
| Synonym | More Synonyms |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 466.6±45.0 °C at 760 mmHg |
| Melting Point | ~235 °C (dec.) |
| Molecular Formula | C10H12N2O3 |
| Molecular Weight | 208.214 |
| Flash Point | 236.0±28.7 °C |
| Exact Mass | 208.084793 |
| PSA | 106.41000 |
| LogP | 1.09 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.626 |
| InChIKey | YGPSJZOEDVAXAB-UHFFFAOYSA-N |
| SMILES | Nc1ccccc1C(=O)CC(N)C(=O)O |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| HS Code | 2922509090 |
| Precursor 8 | |
|---|---|
| DownStream 7 | |
| HS Code | 2922509090 |
|---|---|
| Summary | 2922509090. other amino-alcohol-phenols, amino-acid-phenols and other amino-compounds with oxygen function. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
|
Metabolite profile analysis reveals association of vitamin B-6 with metabolites related to one-carbon metabolism and tryptophan catabolism but not with biomarkers of inflammation in oral contraceptive users and reveals the effects of oral contraceptives on these processes.
J. Nutr. 145(1) , 87-95, (2015) The use of oral contraceptives (OCs) has been associated with low plasma pyridoxal 5'-phosphate (PLP). The functional consequences are unclear.To determine whether functional vitamin B-6 insufficiency... |
|
|
Automated screening of urine samples for carbohydrates, organic and amino acids after treatment with urease.
J. Chromatogr. A. 562(1-2) , 125-38, (1991) Eighty-five clinical urine samples and nineteen urine samples previously found by other laboratories to suggest genetic metabolic defects were prepared for trimethylsilylation by treatment with urease... |
|
|
Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Brain 115 ( Pt 5) , 1249-73, (1992) Neurological dysfunction, seizures and brain atrophy occur in a broad spectrum of acute and chronic neurological diseases. In certain instances, over-stimulation of N-methyl-D-aspartate receptors has ... |
| DL-Kynurenin |
| rac Kynurenine-13C2,15N |
| EINECS 206-445-9 |
| Alanine, 3-anthraniloyl-, DL- |
| DL-2-Amino-3-(2-aminobenzoyl)propionic acid |
| Alanine, 3-anthraniloyl- |
| Kynurenin |
| (±)-Kynurenine |
| 3-anthraniloyl-alanine |
| 3-Anthraniloylalanine |
| Benzenebutanoic acid, α,2-diamino-γ-oxo- |
| MFCD00025194 |
| DL-kynurenine |
| Alanine,3-anthraniloyl |
| racKynurenine |
| Quinurenine |
| 3-Anthraniloyl-DL-alanine |
| Kynurenine |
| 2-Amino-4-(2-amino-phenyl)-4-oxo-buttersaeure |
| α,2-diamino-γ-oxo-Benzenebutanoic acid |
| 2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid |